TER MEULEN JAN HENRIK (Chief Scientific Officer) sold 3.9% of their position (3.41K shares) of IMMUNE DESIGN CORP. on the open market
Open‑market sale worth $5.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/7/2019ACC: 0001209191-19-002670
Officer· Chief Scientific Officer
Since Jul 2018
+141.59K
Net shares
Net buyer
$5.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
145K acquired · 3.41K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
40.1%
1/3/2019
62.40K→87.40K
Common Stock
Direct
Shares
−3.41K
Price / share
$1.59
Trade value
$5.41K
% of position
3.9%
1/7/2019
87.40K→83.98K
Total
Net shares
+21.59K
Net value
-$5.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2019 | A · Award | +25K | — | — | 40.1% | 62.40K | 87.40K |
| Common Stock Direct | 1/7/2019 | S · Sale | −3.41K | $1.59 | $5.41K | 3.9% | 87.40K | 83.98K |
| Total | +21.59K | -$5.41K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
120K shares
Shares
+120K
Strike price
1.31
Held after
120K
Exercisable
—
1/3/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock120K shares | 1/3/2019 | A · Award | +120K | 1.31 | — | 120K |